Chinmay K. Patel, D.O.
Hoffman Estates, Illinois, United States
Family practice physician in Hoffman Estates, Illinois
1786 Moon Lake Blvd # 206, Hoffman Estates, IL 60169
About Chinmay K. Patel, D.O.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
Biogen
1
Memory Pharmaceuticals
1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1
Clinical Trials at Chinmay K. Patel, D.O.
During the past decade, Chinmay K. Patel, D.O. conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on
average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia
2007-12-01
Unknown status
160
An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia
2010-10-01
2011-08-01
Completed
259
A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures.
2013-04-03
2019-02-20
Completed
219
An Outpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms of Schizophrenia
2013-10-01
2014-10-01
Terminated
240
A Study To Evaluate The Safety And Efficacy Of PF-04958242 In Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)
2016-08-29
2016-09-26
Terminated
35
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Chinmay K. Patel, D.O.
According to Clinical.Site data, the most researched conditions in "Chinmay K. Patel, D.O." are
"Schizophrenia" (2 trials), "Cognitive Impairment Associated With Schizophrenia" (1 trials), "Cognitive Impairment Associated With Schizophrenia (CIAS)" (1 trials) and "Generalized Tonic Clonic Seizures" (1 trials). Many other conditions were trialed in "Chinmay K. Patel, D.O." in a lesser frequency.
Clinical Trials Intervention Types at Chinmay K. Patel, D.O.
Most popular intervention types in "Chinmay K. Patel, D.O." are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "PF-02545920" (2 trials), "MEM 3454" (1 trials), "PF-04958242" (1 trials) and "Placebo for MEM 3454" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Chinmay K. Patel, D.O.
The vast majority of trials in "Chinmay K. Patel, D.O." are
5 trials for "All" genders.
Clinical Trials Status at Chinmay K. Patel, D.O.
Currently, there are NaN active trials in "Chinmay K. Patel, D.O.".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Chinmay K. Patel, D.O.,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Chinmay K. Patel, D.O., 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".